US Stock MarketDetailed Quotes

AMRX Amneal Pharmaceuticals

Watchlist
  • 8.390
  • +0.070+0.84%
Close Nov 22 16:00 ET
2.60BMarket Cap-9870P/E (TTM)

Amneal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
74.20%141.77M
449.55%39.66M
-103.16%-4.41M
430.84%345.58M
683.13%135.82M
-13.02%81.39M
90.96%-11.35M
16.09%139.71M
-73.08%65.1M
-136.82%-23.29M
Net income from continuing operations
-53.03%11.76M
-43.45%16.79M
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
1,147.41%25.03M
112.36%29.68M
-56.25%-10.09M
-1,363.21%-254.79M
71.37%-5.86M
Operating gains losses
-190.72%-2.83M
33.57%569K
176.04%1.51M
-105.06%-768K
-216.20%-2.33M
-35.97%3.12M
-91.75%426K
-163.28%-1.99M
8,580.00%15.19M
645.72%2.01M
Depreciation and amortization
3.07%58.96M
-2.69%55.57M
-4.51%55.53M
-4.49%229.4M
-6.75%56.93M
-7.15%57.21M
-4.33%57.11M
0.58%58.15M
2.90%240.18M
-0.21%61.06M
Other non cash items
-77.71%1.89M
28.43%-1.85M
-75.04%1.64M
154.59%44.41M
401.19%31.95M
97.19%8.49M
-180.26%-2.58M
84.85%6.56M
14.86%17.45M
678.40%6.37M
Change In working capital
223.12%42.77M
52.90%-56.72M
-122.06%-11.97M
21.28%-47.19M
139.72%53.7M
-712.66%-34.74M
-735.91%-120.43M
7.16%54.28M
55.13%-59.95M
-521.76%-135.21M
-Change in receivables
213.16%21.96M
21.98%-100.74M
-128.37%-55.74M
259.10%125.8M
169.45%77.88M
-132.46%-19.4M
14.49%-129.11M
58.07%196.44M
-384.80%-79.07M
-225.89%-112.12M
-Change in inventory
-1.25%-43.1M
38.85%-23.25M
45.80%-12.2M
-23.23%-126.18M
-108.58%-23.09M
-64.15%-42.57M
4.59%-38.02M
11.90%-22.51M
-108.91%-102.4M
-166.57%-11.07M
-Change in prepaid assets
189.39%6.34M
20.16%3.29M
-140.15%-11.71M
282.66%37.81M
-70.62%13M
-108.30%-7.09M
102.37%2.74M
759.28%29.16M
144.96%9.88M
703.01%44.26M
-Change in payables and accrued expense
67.76%57.57M
45.52%63.98M
145.47%67.67M
-175.79%-84.62M
74.96%-14.09M
130.23%34.32M
-86.48%43.96M
-240.96%-148.81M
341.19%111.64M
-493.57%-56.28M
Cash from discontinued investing activities
Operating cash flow
74.20%141.77M
449.55%39.66M
-103.16%-4.41M
430.84%345.58M
683.13%135.82M
-13.02%81.39M
90.96%-11.35M
16.09%139.71M
-73.08%65.1M
-136.82%-23.29M
Investing cash flow
Cash flow from continuing investing activities
-53.70%-20.71M
47.37%-6.47M
-68.36%-19.76M
60.31%-69.19M
-176.40%-31.69M
72.68%-13.48M
23.78%-12.28M
87.95%-11.74M
10.23%-174.31M
86.82%-11.47M
Net PPE purchase and sale
-37.16%-17.11M
3.86%-10.7M
11.75%-10.06M
4.09%-46.8M
-2.84%-11.79M
28.84%-12.48M
-56.46%-11.13M
10.11%-11.4M
4.21%-48.8M
36.49%-11.47M
Net intangibles purchase and sale
-260.00%-3.6M
34.78%-750K
-2,769.82%-9.7M
46.44%-22.39M
---19.9M
96.86%-1M
88.50%-1.15M
---338K
-2,358.82%-41.8M
--0
Net business purchase and sale
--0
----
----
--0
--0
--0
----
----
42.19%-84.71M
--0
Net other investing changes
----
----
----
----
----
----
----
----
-80.00%1M
--0
Cash from discontinued investing activities
Investing cash flow
-53.70%-20.71M
47.37%-6.47M
-68.36%-19.76M
60.31%-69.19M
-176.40%-31.69M
72.68%-13.48M
23.78%-12.28M
87.95%-11.74M
10.23%-174.31M
86.82%-11.47M
Financing cash flow
Cash flow from continuing financing activities
-6.65%-92.35M
-186.28%-35.09M
-79.50%-23.16M
-99.37%-212.57M
-354.87%-100.83M
-87.69%-86.59M
-152.72%-12.26M
79.05%-12.9M
22.81%-106.62M
26.96%-22.17M
Net issuance payments of debt
-61.67%-87.21M
-630.06%-27M
-309.47%-15.38M
159.19%22.65M
463.44%64.16M
-26.61%-53.94M
-83.98%5.09M
174.94%7.34M
51.66%-38.27M
77.39%-17.65M
Proceeds from stock option exercised by employees
51.23%617K
--358K
--28K
-31.87%451K
--43K
-3.55%408K
--0
--0
-22.39%662K
--0
Net other financing activities
82.59%-5.75M
51.31%-8.45M
61.43%-7.81M
-241.51%-235.68M
-3,556.92%-165.04M
-737.32%-33.05M
-100.22%-17.35M
60.99%-20.24M
-15.41%-69.01M
-109.46%-4.51M
Cash from discontinued financing activities
Financing cash flow
-6.65%-92.35M
-186.28%-35.09M
-79.50%-23.16M
-99.37%-212.57M
-354.87%-100.83M
-87.69%-86.59M
-152.72%-12.26M
79.05%-12.9M
22.81%-106.62M
26.96%-22.17M
Net cash flow
Beginning cash position
-56.69%49.62M
-65.83%51.62M
181.34%99.11M
-86.28%35.23M
-0.30%95.61M
16.70%114.58M
-30.24%151.07M
-86.28%35.23M
-26.04%256.74M
-69.13%95.89M
Current changes in cash
253.78%28.72M
94.72%-1.89M
-141.13%-47.33M
129.57%63.82M
105.80%3.3M
-885.96%-18.67M
69.69%-35.89M
397.95%115.08M
-138.53%-215.83M
-5.30%-56.93M
Effect of exchange rate changes
102.33%7K
83.22%-101K
-121.51%-165K
101.14%65K
105.38%201K
24.18%-301K
-2,508.00%-602K
148.79%767K
-5,671.57%-5.68M
-2,200.56%-3.74M
End cash Position
-18.06%78.35M
-56.69%49.62M
-65.83%51.62M
181.34%99.11M
181.34%99.11M
-0.30%95.61M
16.70%114.58M
-30.24%151.07M
-86.28%35.23M
-86.28%35.23M
Free cash flow
78.27%121.06M
219.36%28.2M
-118.89%-24.17M
1,184.09%276.39M
399.59%104.13M
53.51%67.91M
83.43%-23.63M
18.87%127.98M
-113.48%-25.5M
-178.98%-34.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 74.20%141.77M449.55%39.66M-103.16%-4.41M430.84%345.58M683.13%135.82M-13.02%81.39M90.96%-11.35M16.09%139.71M-73.08%65.1M-136.82%-23.29M
Net income from continuing operations -53.03%11.76M-43.45%16.79M-709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M1,147.41%25.03M112.36%29.68M-56.25%-10.09M-1,363.21%-254.79M71.37%-5.86M
Operating gains losses -190.72%-2.83M33.57%569K176.04%1.51M-105.06%-768K-216.20%-2.33M-35.97%3.12M-91.75%426K-163.28%-1.99M8,580.00%15.19M645.72%2.01M
Depreciation and amortization 3.07%58.96M-2.69%55.57M-4.51%55.53M-4.49%229.4M-6.75%56.93M-7.15%57.21M-4.33%57.11M0.58%58.15M2.90%240.18M-0.21%61.06M
Other non cash items -77.71%1.89M28.43%-1.85M-75.04%1.64M154.59%44.41M401.19%31.95M97.19%8.49M-180.26%-2.58M84.85%6.56M14.86%17.45M678.40%6.37M
Change In working capital 223.12%42.77M52.90%-56.72M-122.06%-11.97M21.28%-47.19M139.72%53.7M-712.66%-34.74M-735.91%-120.43M7.16%54.28M55.13%-59.95M-521.76%-135.21M
-Change in receivables 213.16%21.96M21.98%-100.74M-128.37%-55.74M259.10%125.8M169.45%77.88M-132.46%-19.4M14.49%-129.11M58.07%196.44M-384.80%-79.07M-225.89%-112.12M
-Change in inventory -1.25%-43.1M38.85%-23.25M45.80%-12.2M-23.23%-126.18M-108.58%-23.09M-64.15%-42.57M4.59%-38.02M11.90%-22.51M-108.91%-102.4M-166.57%-11.07M
-Change in prepaid assets 189.39%6.34M20.16%3.29M-140.15%-11.71M282.66%37.81M-70.62%13M-108.30%-7.09M102.37%2.74M759.28%29.16M144.96%9.88M703.01%44.26M
-Change in payables and accrued expense 67.76%57.57M45.52%63.98M145.47%67.67M-175.79%-84.62M74.96%-14.09M130.23%34.32M-86.48%43.96M-240.96%-148.81M341.19%111.64M-493.57%-56.28M
Cash from discontinued investing activities
Operating cash flow 74.20%141.77M449.55%39.66M-103.16%-4.41M430.84%345.58M683.13%135.82M-13.02%81.39M90.96%-11.35M16.09%139.71M-73.08%65.1M-136.82%-23.29M
Investing cash flow
Cash flow from continuing investing activities -53.70%-20.71M47.37%-6.47M-68.36%-19.76M60.31%-69.19M-176.40%-31.69M72.68%-13.48M23.78%-12.28M87.95%-11.74M10.23%-174.31M86.82%-11.47M
Net PPE purchase and sale -37.16%-17.11M3.86%-10.7M11.75%-10.06M4.09%-46.8M-2.84%-11.79M28.84%-12.48M-56.46%-11.13M10.11%-11.4M4.21%-48.8M36.49%-11.47M
Net intangibles purchase and sale -260.00%-3.6M34.78%-750K-2,769.82%-9.7M46.44%-22.39M---19.9M96.86%-1M88.50%-1.15M---338K-2,358.82%-41.8M--0
Net business purchase and sale --0----------0--0--0--------42.19%-84.71M--0
Net other investing changes ---------------------------------80.00%1M--0
Cash from discontinued investing activities
Investing cash flow -53.70%-20.71M47.37%-6.47M-68.36%-19.76M60.31%-69.19M-176.40%-31.69M72.68%-13.48M23.78%-12.28M87.95%-11.74M10.23%-174.31M86.82%-11.47M
Financing cash flow
Cash flow from continuing financing activities -6.65%-92.35M-186.28%-35.09M-79.50%-23.16M-99.37%-212.57M-354.87%-100.83M-87.69%-86.59M-152.72%-12.26M79.05%-12.9M22.81%-106.62M26.96%-22.17M
Net issuance payments of debt -61.67%-87.21M-630.06%-27M-309.47%-15.38M159.19%22.65M463.44%64.16M-26.61%-53.94M-83.98%5.09M174.94%7.34M51.66%-38.27M77.39%-17.65M
Proceeds from stock option exercised by employees 51.23%617K--358K--28K-31.87%451K--43K-3.55%408K--0--0-22.39%662K--0
Net other financing activities 82.59%-5.75M51.31%-8.45M61.43%-7.81M-241.51%-235.68M-3,556.92%-165.04M-737.32%-33.05M-100.22%-17.35M60.99%-20.24M-15.41%-69.01M-109.46%-4.51M
Cash from discontinued financing activities
Financing cash flow -6.65%-92.35M-186.28%-35.09M-79.50%-23.16M-99.37%-212.57M-354.87%-100.83M-87.69%-86.59M-152.72%-12.26M79.05%-12.9M22.81%-106.62M26.96%-22.17M
Net cash flow
Beginning cash position -56.69%49.62M-65.83%51.62M181.34%99.11M-86.28%35.23M-0.30%95.61M16.70%114.58M-30.24%151.07M-86.28%35.23M-26.04%256.74M-69.13%95.89M
Current changes in cash 253.78%28.72M94.72%-1.89M-141.13%-47.33M129.57%63.82M105.80%3.3M-885.96%-18.67M69.69%-35.89M397.95%115.08M-138.53%-215.83M-5.30%-56.93M
Effect of exchange rate changes 102.33%7K83.22%-101K-121.51%-165K101.14%65K105.38%201K24.18%-301K-2,508.00%-602K148.79%767K-5,671.57%-5.68M-2,200.56%-3.74M
End cash Position -18.06%78.35M-56.69%49.62M-65.83%51.62M181.34%99.11M181.34%99.11M-0.30%95.61M16.70%114.58M-30.24%151.07M-86.28%35.23M-86.28%35.23M
Free cash flow 78.27%121.06M219.36%28.2M-118.89%-24.17M1,184.09%276.39M399.59%104.13M53.51%67.91M83.43%-23.63M18.87%127.98M-113.48%-25.5M-178.98%-34.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data